Market Closed -
Other stock markets
|
Pre-market 09:24:17 am | |||
224.9 USD | +2.16% | 224.1 | -0.37% |
May. 31 | Biogen: Brussels grants marketing authorization for Charcot disease | CF |
May. 31 | Disaster averted |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.07% | 32.75B | |
-1.85% | 89.87B | |
-3.95% | 37.57B | |
+62.80% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.84% | 9.11B | |
-19.53% | 7.32B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- HC Wainwright Adjusts Biogen's Price Target to $300 From $325